Monitoring contractile forces during airway constriction

监测气道收缩期间的收缩力

基本信息

项目摘要

Project summary: Among all factors known to antagonize bronchoconstriction in a healthy lung, a deep breath is among the most effective. In the asthmatic lung, however, this protective phenomenon is substantially at- tenuated and during a spontaneous asthmatic attack it is sometimes even reversed. Some have suggested that the inability of a deep breath to dilate the constricted asthmatic airway might be an important cause of ex- cessive airway narrowing. To explain these observations, our recent findings call attention to the extent to which breathing actually stretched the airway wall, i.e. the magnitude of circumferential strain that is imposed. The circumferential strain, in turn, must vary inversely as a function of two physical factors: (i) stiffness of the non-contractile elements of the cells and extracellular matrix (ECM) in the airway wall, and, (ii) force generated by the airway smooth muscle (ASM) itself. However, it has been nearly impossible to directly measure these factors and their relative contributions in the settings of the intraparenchymal human airway. In the absence of such knowledge, governing mechanisms will remain poorly elucidated and key pathophysiological insights will remain hidden. For example, in asthma, does enhanced ECM stiffness render the airway refractory to the beneficial effects of deep inspirations? Or is the disease pathophysiology dominated by aberrant ASM con- tractility? To find answers to these questions, in this foundational grant, we propose to develop novel enabling measurement technologies. Using a biomechanical approach that we have pioneered called traction force mi- croscopy (TFM), we propose in aim 1 to measure contractile forces generated by the ASM that is situated with- in intact human intraparenchymal airways and subjected to simulated breathing. We propose in aim 2 to de- velop new technology to measure in situ stiffness of extracellular matrix (ECM) components of the airway wall and to correlate local ECM stiffness with local cell-ECM borne stresses.
项目摘要:在健康肺中拮抗支气管收缩的所有因素中,深呼吸 是最有效的。然而,在哮喘肺中,这种保护现象基本上是 在自发的哮喘发作中,有时甚至会逆转。有些人建议 深呼吸无法扩张的哮喘性气道可能是事实的重要原因 戒断气道变窄。为了解释这些观察结果,我们最近的发现呼吁关注 呼吸实际上伸展了气道壁,即施加的圆周菌株的大小。 反过来,周向应变必须随两个物理因素的函数而变化:(i) 呼吸道壁中细胞和细胞外基质(ECM)的非收缩元件,以及(ii)产生的力 通过气道平滑肌(ASM)本身。但是,几乎不可能直接测量这些 因素及其在人体内气道环境中的相对贡献。在没有 这样的知识,理事机制将保持较差的阐明,关键的病理生理见解将 保持隐藏。例如,在哮喘中,确实增强了ECM刚度使气道耐火 深层灵感的有益影响?还是疾病的病理生理学以异常的ASM为主 易于疗程?为了找到这些问题的答案,在这项基础赠款中,我们建议开发新颖的实现 测量技术。使用一种生物力学方法,我们开创了称为牵引力mi的率 我们在AIM 1中提出crscopy(TFM),以测量ASM产生的收缩力,该收缩力与位于 在完整的人体内气道中,并受到模拟呼吸。我们建议在AIM 2中脱颖而出 维洛普新技术,以测量气道墙的细胞外基质(ECM)组件的原位刚度 并将局部ECM刚度与局部细胞ECM寄生应力相关联。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Vimentin intermediate filaments control actin stress fiber assembly through GEF-H1 and RhoA.
  • DOI:
    10.1242/jcs.196881
  • 发表时间:
    2017-03-01
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Jiu Y;Peränen J;Schaible N;Cheng F;Eriksson JE;Krishnan R;Lappalainen P
  • 通讯作者:
    Lappalainen P
Substrate stiffening promotes VEGF-A functions via the PI3K/Akt/mTOR pathway.
Traction Force Screening Enabled by Compliant PDMS Elastomers.
由合规 PDMS 弹性体实现牵引力筛选。
  • DOI:
    10.1016/j.bpj.2018.02.045
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    3.4
  • 作者:
    Yoshie,Haruka;Koushki,Newsha;Kaviani,Rosa;Tabatabaei,Mohammad;Rajendran,Kavitha;Dang,Quynh;Husain,Amjad;Yao,Sean;Li,Chuck;Sullivan,JohnK;Saint-Geniez,Magali;Krishnan,Ramaswamy;Ehrlicher,AllenJ
  • 通讯作者:
    Ehrlicher,AllenJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAMASWAMY KRISHNAN其他文献

RAMASWAMY KRISHNAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAMASWAMY KRISHNAN', 18)}}的其他基金

Screening for inhibitors of allergen-associated airway smooth muscle contraction
筛选过敏原相关气道平滑肌收缩抑制剂
  • 批准号:
    10176398
  • 财政年份:
    2020
  • 资助金额:
    $ 27.62万
  • 项目类别:
Screening for inhibitors of allergen-associated airway smooth muscle contraction
筛选过敏原相关气道平滑肌收缩抑制剂
  • 批准号:
    10057021
  • 财政年份:
    2020
  • 资助金额:
    $ 27.62万
  • 项目类别:
Cooperative targeting of pharmacomechanical coupling and the actin cytoskeleton to regulate ASM contraction
药物机械耦合和肌动蛋白细胞骨架的协同靶向调节 ASM 收缩
  • 批准号:
    9983151
  • 财政年份:
    2019
  • 资助金额:
    $ 27.62万
  • 项目类别:
Cooperative targeting of pharmacomechanical coupling and the actin cytoskeleton to regulate ASM contraction
药物机械耦合和肌动蛋白细胞骨架的协同靶向调节 ASM 收缩
  • 批准号:
    10188621
  • 财政年份:
    2019
  • 资助金额:
    $ 27.62万
  • 项目类别:
Cooperative targeting of pharmacomechanical coupling and the actin cytoskeleton to regulate ASM contraction
药物机械耦合和肌动蛋白细胞骨架的协同靶向调节 ASM 收缩
  • 批准号:
    10434061
  • 财政年份:
    2019
  • 资助金额:
    $ 27.62万
  • 项目类别:

相似国自然基金

探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
  • 批准号:
    82270081
  • 批准年份:
    2022
  • 资助金额:
    76 万元
  • 项目类别:
    面上项目
多肽纳米纤维水凝胶对灵长类动物急性脊髓损伤后脱髓鞘和再髓鞘化的保护作用及其机制
  • 批准号:
    81972064
  • 批准年份:
    2019
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
建立脑内急性基因编辑的孤独症非人灵长类动物模型
  • 批准号:
  • 批准年份:
    2019
  • 资助金额:
    100 万元
  • 项目类别:
    专项基金项目
氨转运蛋白Rhcg在急性肝衰竭动物氨致脑水肿发生中的作用机制
  • 批准号:
  • 批准年份:
    2019
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
呼气末正压与动态/静态机械能比值的相关性研究:针对不同肺损伤模型的动物实验及初步临床验证
  • 批准号:
    81871582
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目

相似海外基金

Novel Anti-Stroke Agents Targeting Toxic Protein Aggregation
针对有毒蛋白聚集的新型抗中风药物
  • 批准号:
    10589978
  • 财政年份:
    2023
  • 资助金额:
    $ 27.62万
  • 项目类别:
Core D: Nonhuman Primates
核心 D:非人类灵长类动物
  • 批准号:
    10425029
  • 财政年份:
    2022
  • 资助金额:
    $ 27.62万
  • 项目类别:
Microbial Synthesis of Therapeutic Bile Acids for Alzheimer's Disease
微生物合成治疗阿尔茨海默病的胆汁酸
  • 批准号:
    10602316
  • 财政年份:
    2020
  • 资助金额:
    $ 27.62万
  • 项目类别:
Microbial Synthesis of Therapeutic Bile Acids
治疗性胆汁酸的微生物合成
  • 批准号:
    10010076
  • 财政年份:
    2020
  • 资助金额:
    $ 27.62万
  • 项目类别:
Targeting TLR Signaling Pathways to Blunt Pathogen-mediated Acute Lung Injury
靶向 TLR 信号通路以减弱病原体介导的急性肺损伤
  • 批准号:
    9306674
  • 财政年份:
    2017
  • 资助金额:
    $ 27.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了